N/A
Completed N=27
Hearing Aid Signal Processing Comparative Study
Hearing Loss, Sensorineural
Source: ClinicalTrials.gov NCT04839289 ↗
Enrolled (actual)
27
Serious AEs
0.0%
Results posted
Mar 2023
Primary outcomePrimary: Standardized Validated Questionnaire Measuring Hearing Aid Sound Quality for First Study Set Worn, i.e. Study Set A for Arm A-B-A and Study Set B for Arm B-A-B — 7.16; 7.12 score on a scale
Summary
Participants will be fit with each of two hearing instruments in an ABA cross-over design. The study will consist of a total of three approximately 10-day home trials with the devices. Participants will be asked to provide qualitative feedback to investigators regarding the performance of and their preference for each hearing instrument.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Standardized Validated Questionnaire Measuring Hearing Aid Sound Quality for First Study Set Worn, i.e. Study Set A for Arm A-B-A and Study Set B for Arm B-A-B |
7.16; 7.12 | — |
| PRIMARY Standardized Validated Questionnaire Measuring Hearing Aid Sound Quality for Second Study Set Worn, i.e. Study Set B for Arm A-B-A and Study Set A for Arm B-A-B |
7.61; 6.70 | — |
| PRIMARY Standardized Validated Questionnaire Measuring Hearing Aid Sound Quality for Third Study Set Worn, i.e. Study Set A for Arm A-B-A and Study Set B for Arm B-A-B |
7.28; 7.52 | >0.05 |
| PRIMARY Standard Validated Questionnaire Measuring Satisfaction of Hearing Aid Performance and Features for First Study Set Worn. |
3.94; 3.80 | — |
| PRIMARY Standard Validated Questionnaire Measuring Satisfaction of Hearing Aid Performance and Features for Second Study Set Worn. |
4.24; 3.76 | — |
| PRIMARY Standard Validated Questionnaire Measuring Satisfaction of Hearing Aid Performance and Features for Third Study Set Worn. |
4.12; 3.99 | <.01666667 sig |
Eligibility Criteria
Inclusion Criteria
- Moderate to severe sensorineural hearing loss
- Current hearing aid user
Exclusion Criteria
- Lack of willingness to wear study devices for approximately one month
- Inability to travel to study appointments or to complete questionnaires.
Data sourced from ClinicalTrials.gov (NCT04839289). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.